Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Vir Biotechnology, Inc. (VIR) had Normalized Pre-Tax Income of $80.26M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$238.95M |
|
$80.08M |
|
-- |
|
$238.95M |
|
$165.48M |
|
$73.47M |
|
$6.79M |
|
$80.26M |
|
|
Normalized Pre-Tax Income |
$80.26M |
$80.08M |
|
$80.08M |
|
$80.08M |
|
$80.08M |
|
$73.47M |
|
$76.59M |
|
167.72M |
|
168.88M |
|
$0.48 |
|
$0.47 |
|
| Balance Sheet Financials | |
$573.74M |
|
$50.43M |
|
$641.07M |
|
$1.21B |
|
$94.96M |
|
-- |
|
$137.35M |
|
$232.31M |
|
$982.49M |
|
$957.85M |
|
$982.49M |
|
169.19M |
|
| Cash Flow Statement Financials | |
$-9.06M |
|
$-185.31M |
|
$240.90M |
|
$241.07M |
|
$287.60M |
|
$46.53M |
|
$24.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
30.75% |
|
30.75% |
|
-- |
|
33.59% |
|
33.51% |
|
$-9.48M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
-- |
|
-- |
|
-- |
|
8.15% |
|
8.36% |
|
6.59% |
|
8.15% |
|
$5.81 |
|
$-0.06 |
|
$-0.05 |
|